Cargando…

A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker

BACKGROUND: The human concentrative nucleoside transporter 1 (hCNT1) a product of the SLC28A1 gene is one of the three concentrative nucleoside transporters, with a substrate specificity for physiological pyrimidine nucleosides. It has recently been implicated in tumor suppression. We have unraveled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chunmei, Buolamwini, John K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704654/ https://www.ncbi.nlm.nih.gov/pubmed/31440421 http://dx.doi.org/10.1186/s40164-019-0144-y

Ejemplares similares

Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner
por: Pérez-Torras, S, et al.
Publicado: (2013)

Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug–Drug Interactions
por: Mandíková, Jana, et al.
Publicado: (2016)

Inward- and outward-facing homology modeling of human concentrative nucleoside transporter 3 (hCNT3) predicts an elevator-type transport mechanism
por: Yao, Sylvia Y. M., et al.
Publicado: (2018)

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1
por: Boces-Pascual, Clara, et al.
Publicado: (2021)

Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance
por: Mulinta, Ras, et al.
Publicado: (2017)

Cryo-EM structure of the human concentrative nucleoside transporter CNT3
por: Zhou, Yanxia, et al.
Publicado: (2020)

Concentrative Nucleoside Transporter, CNT, Results in Selective Toxicity of Toyocamycin against Candida albicans
por: Ojima, Yoshihiro, et al.
Publicado: (2022)

The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
por: Skrypek, Nicolas, et al.
Publicado: (2015)

Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters
por: Johnson, Zachary Lee, et al.
Publicado: (2014)

Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice
por: Persaud, Avinash K., et al.
Publicado: (2023)

Genome Sequence of Rhizobium sullae HCNT1 Isolated from Hedysarum coronarium Nodules and Featuring Peculiar Denitrification Phenotypes
por: de Diego-Diaz, B., et al.
Publicado: (2018)

Author Correction: Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice
por: Persaud, Avinash K., et al.
Publicado: (2023)

Mutation in Drosophila concentrative nucleoside transporter 1 alters spermatid maturation and mating behavior
por: Maaroufi, Houda Ouns, et al.
Publicado: (2022)

Novel variants provide differential stabilisation of human equilibrative nucleoside transporter 1 states
por: Boakes, Jessica C., et al.
Publicado: (2022)

Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer
por: Kim, Jaihwan, et al.
Publicado: (2018)

DNA aerogels and DNA-wrapped CNT aerogels for neuromorphic applications
por: Hosseini, Mahshid, et al.
Publicado: (2022)

Concentrative Nucleoside Transporter 3 Is Located on Microvilli of Vaginal Epithelial Cells
por: Webster, Paul, et al.
Publicado: (2020)

Human Concentrative Nucleoside Transporter 3 Transfection with Ultrasound and Microbubbles in Nucleoside Transport Deficient HEK293 Cells Greatly Increases Gemcitabine Uptake
por: Paproski, Robert J., et al.
Publicado: (2013)

Zinc transporter-1 concentrates at the postsynaptic density of hippocampal synapses
por: Sindreu, Carlos, et al.
Publicado: (2014)

Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
por: Pastor-Anglada, Marçal, et al.
Publicado: (2015)

Decreased erythrocyte nucleoside transport and hENT1 transporter expression in glucose 6-phosphate dehydrogenase deficiency
por: Al-Ansari, Mohammad, et al.
Publicado: (2015)

Functional characterization of human equilibrative nucleoside transporter 1
por: Huang, Weiyun, et al.
Publicado: (2016)

Insight into the nucleoside transport and inhibition of human ENT1
por: Wu, Zhixiang, et al.
Publicado: (2022)

Role of the stage-regulated nucleoside transporter TbNT10 in differentiation and adenosine uptake in Trypanosoma brucei
por: Spoerri, Iris, et al.
Publicado: (2007)

Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.
por: Hughes, J. M., et al.
Publicado: (1989)

Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions
por: Spratlin, Jennifer L., et al.
Publicado: (2010)

Simulation of Percolation Threshold, Tunneling Distance, and Conductivity for Carbon Nanotube (CNT)-Reinforced Nanocomposites Assuming Effective CNT Concentration
por: Zare, Yasser, et al.
Publicado: (2020)

Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease
por: Guitart, Xavier, et al.
Publicado: (2017)

Emerging Roles of Nucleoside Transporters
por: Pastor-Anglada, Marçal, et al.
Publicado: (2018)

Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice
por: Anderson, Jason T., et al.
Publicado: (2019)

HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
por: Eltzschig, Holger K., et al.
Publicado: (2005)

Export of RNA-derived modified nucleosides by equilibrative nucleoside transporters defines the magnitude of autophagy response and Zika virus replication
por: Shi, Sheng-Lan, et al.
Publicado: (2021)

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
por: Boyd, Lenka N. C., et al.
Publicado: (2023)

Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions
por: Hermann, Robert, et al.
Publicado: (2021)

Nucleoside triphosphate diphosphohydrolase1 (TcNTPDase-1) gene expression is increased due to heat shock and in infective forms of Trypanosoma cruzi
por: Silva-Gomes, Natália Lins, et al.
Publicado: (2014)

Anticancer Conjugates and Cocktails Based on Methotrexate and Nucleoside Synergism
por: Vortherms, Anthony R., et al.
Publicado: (2009)

Functional Characterization of the Saccharomyces cerevisiae Equilibrative Nucleoside Transporter 1 (ScENT1)
por: Boswell-Casteel, Rebba C., et al.
Publicado: (2018)

Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å
por: Johnson, Zachary Lee, et al.
Publicado: (2012)

Potential role of long non‐coding RNA H19 and Neat1 in haemophilic arthropathy
por: Sarangi, Pratiksha, et al.
Publicado: (2023)

Gestational Diabetes—Placental Expression of Human Equilibrative Nucleoside Transporter 1 (hENT1): Is Delayed Villous Maturation an Adaptive Pattern?
por: Giacometti, Cinzia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b0ds5dgt9e9q6ku33s4994c1kr